Elisa Bergaggio

6PUBLICATIONS
53CO-AUTHORS
Learning sciencesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 12, 2026
Training Tomorrow's Leaders in Cancer Immunology.

Yuqi Tan, B J Kim, Adriana M Mujal

|Aug 25, 2025
Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells.

Tomasz M Grzywa, Alexandra Neeser, Ranjani Ramasubramanian

|Jul 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.

Ines Mota, Enrico Patrucco, Cristina Mastini

|Apr 24, 2019
Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy.

Elisa Bergaggio, Roberto Piva

|Nov 21, 2018
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.

Elisa Bergaggio, Chiara Riganti, Giulia Garaffo

Pageof 1

Frequent Collaborators

3 joint publications

Roberto Chiarle

2 joint publications

Chiara Riganti

2 joint publications

Roberto Piva

2 joint publications

Darrell J Irvine